Research
Molecular
Emerging therapeutic strategies are focusing on novel targets such as growth differentiation factor 15 (GDF15) and bile acid receptors including the farnesoid X receptor (FXR) and Takeda G protein-coupled receptor 5 (TGR5).
Practitioners should stay informed about these novel molecular targets for potential future therapies in obesity management.
StrongSupportsmedium confidence
Emerging therapeutic strategies are focusing on novel targets such as growth differentiation factor 15 (GDF15) and its specific receptor glial cell-line derived neurotrophic factor family receptor α-like (GFRAL), inhibin βE (INHBE), as well as bile acid receptors including the farnesoid X receptor (FXR) and Takeda G protein-coupled receptor 5 (TGR5).
Why this rating
The claim is based on a review of emerging strategies in obesity treatment.
Source
Obesity and emerging intervention strategies: Mechanistic insights and novel drug targets
Xingrong Feng et al. · Chinese Medical Journal · 2025
reviewCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →